Evidence map›Paper›PMID 26795565›Full record

ArticlePloS one2016

The Role of Hippocampal NMDA Receptors in Long-Term Emotional Responses following Muscarinic Receptor Activation.

Alexandre A Hoeller, Ana Paula R Costa, Maíra A Bicca, Filipe C Matheus, Gilliard Lach, Francesca Spiga, Stafford L Lightman, Roger Walz, Graham L Collingridge, Zuner A Bortolotto and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Alexandre A HoellerPostgraduate Program in Medical Sciences, Center of Health Sciences, University Hospital, Federal University of Santa Catarina, Florianópolis, SC, 88040-970, Brazil.
Ana Paula R CostaDepartment of Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC, 88040-970, Brazil.
Maíra A BiccaDepartment of Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC, 88040-970, Brazil.
Filipe C MatheusDepartment of Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC, 88040-970, Brazil.
Gilliard LachDepartment of Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC, 88040-970, Brazil.
Francesca SpigaHenry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, School of Clinical Sciences, University of Bristol, Dorothy Hodgkin Building, Bristol, BS1 3NY, United Kingdom.
Stafford L LightmanHenry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, School of Clinical Sciences, University of Bristol, Dorothy Hodgkin Building, Bristol, BS1 3NY, United Kingdom.
Roger WalzPostgraduate Program in Medical Sciences, Center of Health Sciences, University Hospital, Federal University of Santa Catarina, Florianópolis, SC, 88040-970, Brazil.
Graham L CollingridgeCentre for Synaptic Plasticity, School of Physiology, Pharmacology and Neuroscience, University of Bristol, Dorothy Hodgkin Building, Bristol, BS1 3NY, United Kingdom.
Zuner A BortolottoCentre for Synaptic Plasticity, School of Physiology, Pharmacology and Neuroscience, University of Bristol, Dorothy Hodgkin Building, Bristol, BS1 3NY, United Kingdom.
Thereza C M de LimaDepartment of Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC, 88040-970, Brazil.
Universidade Federal de Santa Catarina · BRUniversity of Bristol · GBInnsbruck Medical University · AT

Funding

Biotechnology and Biological Sciences Research Council BB/H015779/01Biotechnology and Biological Sciences Research Council BB/H015779/1Medical Research Council 90601813Medical Research Council MR/J008893/1Medical Research Council MR/K023098/1
6 · The paper itself

Abstract

Extensive evidence indicates the influence of the cholinergic system on emotional processing. Previous findings provided new insights into the underlying mechanisms of long-term anxiety, showing that rats injected with a single systemic dose of pilocarpine--a muscarinic receptor (mAChR) agonist--displayed persistent anxiogenic-like responses when evaluated in different behavioral tests and time-points (24 h up to 3 months later). Herein, we investigated whether the pilocarpine-induced long-term anxiogenesis modulates the HPA axis function and the putative involvement of NMDA receptors (NMDARs) following mAChRs activation. Accordingly, adult male Wistar rats presented anxiogenic-like behavior in the elevated plus-maze (EPM) after 24 h or 1 month of pilocarpine injection (150 mg/kg, i.p.). In these animals, mAChR activation disrupted HPA axis function inducing a long-term increase of corticosterone release associated with a reduced expression of hippocampal GRs, as well as consistently decreased NMDAR subunits expression. Furthermore, in another group of rats injected with memantine--an NMDARs antagonist (4 mg/kg, i.p.)--prior to pilocarpine, we found inhibition of anxiogenic-like behaviors in the EPM but no further alterations in the pilocarpine-induced NMDARs downregulation. Our data provide evidence that behavioral anxiogenesis induced by mAChR activation effectively yields short- and long-term alterations in hippocampal NMDARs expression associated with impairment of hippocampal inhibitory regulation of HPA axis activity. This is a novel mechanism associated with anxiety-like responses in rats, which comprise a putative target to future translational studies.

Indexed as

AnimalsAnxietyBehavior, AnimalBlotting, WesternEmotionsHippocampusMaleMaze LearningPilocarpineRatsRats, WistarReceptors, MuscarinicReceptors, N-Methyl-D-AspartateSynaptic TransmissionPilocarpineReceptors, MuscarinicReceptors, N-Methyl-D-Aspartate

Identifiers

PMID26795565
PMCPMC4721870
OpenAlexW2268694097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.